$XBI $149.35 (+0.87%) 📈
COVID:
$MRNA (+6.22%) - Swissmedic Authorizes COVID-19 Vaccine Moderna for Use in Switzerland
PIPELINE:
$MESO (-10.18%) - CHF Phase 3 Trial Results Presented at Investor Conference
$MIRM (+5.04%) - News Release Details Mirum Pharmaceuticals Provides Corporate Update
$TVTX (+1.07%) - Travere Therapeutics Announces Orphan Drug Designation for Sparsentan for the Treatment of IgA Nephropathy
$MRUS (+20.30%) - Merus Announces Presentation of Phase 1 Clinical Data for MCLA-158 at the American Society of Clinical Oncology (ASCO) 2021 Gastrointestinal Cancers Symposium
$OTLK (-1.59%) - Leading Ophthalmology Organization Launches Podcast Video with Firas Rahhal, MD, to Explore the Genesis and Promise of Outlook Therapeutics’ ONS-5010/LYTENAVA™ (bevacizumab-vikg)
FINANCIAL:
$MNOV (+0.54%) - MediciNova Enters into US$20 Million Securities Purchase Agreement with a fund managed by 3D Investment Partners
$CERC (+8.87%) - Closed offering priced at $2.60/share
$RGNX (+1.27%) - Closed offering priced at $47/share
$RDHL (-13.66%) - RedHill Biopharma Increases Previously Announced Bought Deal to $25 Million